Personalized Medicine Universe ®
|
 |
Review articles
- Personalized medicine for connective tissue disease: Historical and future perspectives
- M. Kuwana
- Cloning and expansion of antigen-specific T cells using iPS cell technology: Possible use of regenerated T cells in personalized medicine
- H. Kawamoto, K. Masuda, S. Nagano
- Significance of humanized mouse models for evaluating humoral immune response against cancer vaccines
- Y. Kametani, A. Miyamoto, T. Seki, R. Ito, S. Habu, Y. Tokuda
- Association of MTHF 677TT with adverse drug reactions and RFC G80A with non-response and adverse drug reactions in methotrexate therapy
- M. M. AlSabbagh
Original articles
- Assessing antitumor and T cell immune responses by cytokine assay in cancer patients treated with immunotherapy – A pilot study
- A. Morokuma, Y. Saeki, A. Nakamura, H. Sakuma, Y. Ishihara, M. Abe
Short communications
- Predictive factors for the development of bronchial asthma by the age of 3
- N. Kondo, E. Matsui, T. Teramoto, M. Kuwabara, T. Nagata, Y. Furuta, M. Sanada, Ikuko Aoki, M. Kumada
Commentary
- Current state and issues related to cell therapy under the Act on the Safety of Regenerative Medicine
- M. Tobita
Letter to the Editor
- Novel biologic products and Post-Bio strategy
- K. Nishioka
